Axelpharm is suing Wyeth Holdings over a compulsory license for an anticancer drug
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...
The Russian Axelpharm is demanding a compulsory license from the American Pfizer, probably for an antitumor drug based on bosutinib,...